Abstract
Seven species of coronavirus cause acute respiratory illness in humans. Coronavirus HKU 1 (CoV HKU 1) was first described in 2005 in an adult patient with pneumonia in Hong Kong. Although it is a well-known respiratory tract pathogen, there is not much information about its role in hospitalized adults, especially in southern Europe. Here, we describe a case of radiologically demonstrated CoV HKU 1-related bronchiolitis with acute respiratory failure in an adult female without significant comorbidities except obesity.
Keywords:
Coronavirus; acute respiratory failure; bronchiolitis; virus infection.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Bronchiolitis / etiology*
-
Bronchiolitis / therapy
-
Bronchodilator Agents / therapeutic use
-
Ceftriaxone / therapeutic use
-
Coronavirus Infections / complications*
-
Coronavirus Infections / therapy
-
Coronavirus*
-
Female
-
Humans
-
Methylprednisolone / therapeutic use
-
Middle Aged
-
Obesity, Morbid / therapy
-
Oxygen / therapeutic use
-
Pericardial Effusion / etiology*
-
Pericardial Effusion / therapy
-
Respiratory Insufficiency / etiology*
-
Respiratory Insufficiency / therapy
Substances
-
Anti-Bacterial Agents
-
Bronchodilator Agents
-
Ceftriaxone
-
Oxygen
-
Methylprednisolone